52 -10 (84) 2025 - Taylakova D.I., Tursunova G.J. - EVALUATION OF THE IMPACT OF BRONCHIAL ASTHMA AND APPLIED PHARMACOTHERAPY ON THE PERIODONTAL CONDITION IN PATIENTS

EVALUATION OF THE IMPACT OF BRONCHIAL ASTHMA AND APPLIED PHARMACOTHERAPY ON THE PERIODONTAL CONDITION IN PATIENTS

Taylakova D.I. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Tursunova G.J. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Bronchial asthma is a chronic inflammatory pathology of the respiratory tract, accompanied by airway narrowing and excessive mucus secretion, leading to breathing difficulties. A distinctive feature of this disease is episodic airflow obstruction, the severity of which can vary within a short period of time. However, these changes are reversible: in some cases, they resolve spontaneously, while in others they require medical intervention. Therapy for bronchial asthma is based on the use of bronchodilators, corticosteroids, and anticholinergic agents. Most often, these drugs are administered through inhalation — using aerosol inhalers or nebulizers. The consequences of such pharmacological exposure on the oral cavity tissues have become a subject of active discussion among dental specialists. It has been proven that patients who regularly use these medications have an increased predisposition to dental caries, enamel erosion, oral candidiasis, and inflammatory periodontal diseases. Therefore, individuals with bronchial asthma undergoing long-term pharmacotherapy require an individualized approach to the prevention of oral diseases. This review is devoted to the study of the relationship between bronchial asthma and oral health, as well as to the description of preventive and corrective approaches aimed at reducing oral complications in this group of patients.

Keywords: bronchial asthma, beta-2 agonists, dental caries, tooth erosion, inhaled corticosteroids, candidiasis, periodontal diseases, salivation.

First page

283

Last page

291

For citation:Taylakova D.I., Tursunova G.J. - EVALUATION OF THE IMPACT OF BRONCHIAL ASTHMA AND APPLIED PHARMACOTHERAPY ON THE PERIODONTAL CONDITION IN PATIENTS//New Day in Medicine 10(84)2025 283-291 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

1. Иннес ДЖА, Рид ПТ. Респираторные заболевания // В кн.: Бун НА, Колледж НР, Уокер БР, Хантер ДЖА. Принципы и практика медицины Дэвидсона. 20-е изд. Эдинбург: Churchill Livingstone: Elsevier; 2006. С. 670–678.
2. Johansson I., Ericson T. Saliva composition and caries development during protein deficiency and beta-receptor stimulation or inhibition // J Oral Pathol. 1987;16:145–149.
3. Ryberg M., Möller C., Ericson T. Effect of beta 2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children // J Dent Res. 1987;66:1404–1406.
4. Ryberg M., Möller C., Ericson T. Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: a 4-year follow-up study // Scand J Dent Res. 1991;99:212–218.
5. de Almeida Pdel V., Grégio AM., Machado MA., de Lima AA., Azevedo LR. Saliva composition and functions: a comprehensive review // J Contemp Dent Pract. 2008;9:72–80.
6. Steinbacher DM., Glick M. The dental patient with asthma. An update and oral health considerations // J Am Dent Assoc. 2001;132:1229–1239.
7. McDerra EJ., Pollard MA., Curzon ME. The dental status of asthmatic British school children // Pediatr Dent. 1998;20:281–287.
8. Reddy DK., Hegde AM., Munshi AK. Dental caries status of children with bronchial asthma // J Clin Pediatr Dent. 2003;27:293–295.
9. Ersin NK., Gülen F., Eronat N., et al. Oral and dental manifestations of young asthmatics related to medication, severity and duration of condition // Pediatr Int. 2006;48:549–554.
10. Shashikiran ND., Reddy VV., Raju PK. Effect of antiasthmatic medication on dental disease: dental caries and periodontal disease // J Indian Soc Pedod Prev Dent. 2007;25:65–68.

    file

    download